Related Experiment Videos
Insights
Infants respond differently to anesthesia due to unique physiological factors like fluid volume and underdeveloped metabolic systems. Understanding these differences is crucial for administering safer pediatric anesthesia.
Area of Science:
- Anesthesiology
- Pediatric Pharmacology
Background:
- Neonates and infants exhibit distinct physiological characteristics compared to adults.
- These differences significantly impact their responses to anesthetic agents and adjuncts.
Purpose of the Study:
- To elucidate the key pharmacokinetic and pharmacodynamic variations in infants receiving anesthesia.
- To highlight the implications of these differences for safe anesthetic practice in neonates and children.
Main Methods:
- Review of existing literature on pediatric anesthesia and drug metabolism.
- Analysis of physiological differences influencing drug distribution, metabolism, and excretion in infants.
Main Results:
- Infants have altered drug distribution due to higher extracellular fluid and blood volumes.
- Neonatal hepatic enzyme systems and glomerular filtration are immature, affecting drug metabolism and excretion.
- Infants show increased sensitivity to certain drugs but require higher doses of others (e.g., ketamine, suxamethonium) on a weight basis.
- Alveolar uptake of inhalation anesthetics is faster in infants, and their anesthetic requirements are higher for a given surgical stimulus.
Conclusions:
- Significant age-related differences exist in drug response, necessitating tailored anesthetic approaches for infants.
- Awareness of altered pharmacokinetics and pharmacodynamics enables the provision of rational and safer anesthesia for pediatric patients.
Abstract:
The young infant differs from the adult in his quantitative responses to many anaesthetic drugs and adjuncts. In the neonate, the larger extracellular fluid volume and blood volume, the smaller muscle mass and fat stores, and presumable greater blood flow to the central organs, not only influence the distribution of drugs to their active site but also secondary redistribution. The neonatal hepatic anzyme systems responsible for the metabolism of drugs are incompletely developed or absent. Glomerular filtration, important for drug excretion, is inefficient by adult standards. The neonate has increased toxicity and sensitivity to a variety of sedative-hypnotics, narcotics, and local anaesthetics. On the other hand, the infant requires more suxamethonium (succinylcholine) and ketamine on a weight basis that does the adult. The response of some infants to non-depolarising muscle relaxants resembles that of the myasthenic patients. The rate of uptake of alveolar levels of inhalation anesthetics is more rapid in infants and children than in adults. In addition, the neonate requires more anaesthetic than the adult for a given surgical stimulus. Biotransformation of inhalation anaesthetics is limited in neonates. Awareness of these pharmacological differences and their probable explanations allows one to provide rational, safer anaesthesia to infants.